Genetische Diagnostik der Herzinsuffizienz

Literatur

• 1 Kannel W B. Vital epidemiologic clues in heart failure.  J Clin Epidemiol. 2000;  53 229-235
• 2 MacIntyre K, Capewell S, Stewart S, Chalmers J W, Boyd J, Finlayson A, Redpath A, Pell J P, McMurray J J. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.  Circulation. 2000;  102 1126-1131
• 3 Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden L H, Cuffe M S, Blazing M A. et al . Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.  Arch Intern Med. 2001;  161 1849-1856
• 4 Boersma E, Keil U, de Bacquer D, de Backer G, Pyorala K, Poldermans D, Leprotti C. et al . Blood pressure is insufficiently controlled in European patients with established coronary heart disease.  J Hypertens. 2003;  21 1831-1840
• 5 Archacki S, Wang Q. Expression profiling of cardiovascular disease.  Hum Genomics. 2004;  1 355-370
• 6 Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A, Osterziel K J. et al . Expression profiling of human idiopathic dilated cardiomyopathy.  Cardiovasc Res. 2003;  59 400-411
• 7 Cascorbi I, Paul M, Kroemer H K. Pharmacogenomics of heart failure - focus on drug disposition and action.  Cardiovasc Res. 2004;  64 32-39
• 8 Crackower M A, Sarao R, Oudit G Y, Yagil C, Kozieradzki I, Scanga S E, Oliveira-dos-Santos A J. et al . Angiotensin-converting enzyme 2 is an essential regulator of heart function.  Nature. 2002;  417 822-828
• 9 Small K M, Wagoner L E, Levin A M, Kardia S L, Liggett S B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.  N Engl J Med. 2002;  347 1135-1142
• 10 Group M-H S. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).  Lancet. 1999;  353 2001-2007
• 11 White H L, de Boer R A, Maqbool A, Greenwood D, van Veldhuisen D J, Cuthbert R, Ball S G, Hall A S, Balmforth A J. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.  Eur J Heart Fail. 2003;  5 463-468
• 12 Schönberger J, Seidman C E. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.  Am J Hum Genet. 2001;  69 249-260
• 13 Seidman J G, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.  Cell. 2001;  104 557-567
• 14 Olson T M, Michels V V, Thibodeau S N, Tai Y S, Keating M T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.  Science. 1998;  280 750-752
• 15 Taylor M R, Fain P R, Sinagra G, Robinson M L, Robertson A D, Carniel E, di Lenarda A. et al . Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.  J Am Coll Cardiol. 2003;  41 771-780
• 16 Tanigawa G, Jarcho A J, Kaas S, Solomon D S, Vosberg H-P, Seidman J G, Seidman C. A Molecular Basis for Familial Hypertrophic Cardiomyopathie: An a/β Cardiac Myosin Heavy Chain Hybrid Gene.  Cell. 1990;  62 991-998
• 17 Arad M, Seidman J G, Seidman C E. Phenotypic diversity in hypertrophic cardiomyopathy.  Hum Mol Genet. 2002;  11 2499-2506
• 18 Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg H P, Seidmann J G, Seidmann C E. Tropomyosin and Cardiac Troponin T Mutations Cause Familial Hypertrophic Cardiomyopathy: A Disease of the Sarcomere.  Cell. 1994;  77 701-712
• 19 Geier C, Perrot A, Ozcelik C, Binner P, Counsell D, Hoffmann K, Pilz B. et al . Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.  Circulation. 2003;  107 1390-1395
• 20 Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.  Hum Mol Genet. 2001;  10 1215-1220
• 21 Jung M, Poepping I, Perrot A, Ellmer A E, Wienker T F, Dietz R, Reis A, Osterziel K J. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22.  Am J Hum Genet. 1999;  65 1068-1077
• 22 Maron B J, Niimura H, Casey S A, Soper M K, Wright G B, Seidman J G, Seidman C E. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.  J Am Coll Cardiol. 2001;  38 315-321
• 23 Nimura H, Bachinski L L, Sangwatanaroj S, Watkins H, Cudley A E, McKenna W, Kristinsson A. et al . Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.  New England Journal of Medicine. 1998;  338 1248-1257
• 24 Fatkin D, MacRae C, Sasaki T, Wolff M R, Porcu M, Frenneaux M, Atherton J. Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease.  New England Journal of Medicine. 1999;  341 1715-1724